Case Report: Motivational ambivalence and family dynamics in severe adolescent anorexia nervosa treated in a Mexican multidisciplinary setting
Abstract
This case report describes the clinical course of two adolescent females (ages 12 and 14) with severe restrictive-type anorexia nervosa (AN) and comorbid anxiety and depressive symptoms. Both presented with extreme malnutrition (BMI-for-age <1st percentile), amenorrhea, distorted body image, and marked ambivalence toward weight restoration. Their families, characterized as structured, were engaged with the treatment. Care involved short-term hospitalization followed by intensive outpatient multidisciplinary treatment integrating cognitive-behavioral and dialectical behavior therapy strategies, nutritional rehabilitation, psychopharmacology, and structured caregiver involvement, alongside a psychodynamic-systemic family intervention informed by initial assessment. This model provided a framework to identify relational and emotional processes underlying motivational ambivalence. Over 6 months, both patients achieved weight restoration (approximately 50th-60th percentile BMI-for-age), with reduced eating disorder (ED) symptoms and improved emotional awareness, accompanied by changes in family functioning. However, residual anxiety, perfectionism, fluctuating insight, family conflict, and treatment fatigue persisted. One patient discontinued treatment prematurely despite clinical stabilization, with family and couple conflict. These cases highlight the complicated interaction between symptom remission, motivational ambivalence, and family dynamics in adolescent AN, emphasizing…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.